PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BUCKINGHAM STRATEGIC PARTNERS, LLC | 19,220 | $50,549 | 0.00% |
| Jump Financial, LLC | 24,690 | $64,935 | 0.00% |
| LSV ASSET MANAGEMENT | 86,651 | $228 | 0.00% |
| SEI INVESTMENTS CO | 285,657 | $751,276 | 0.00% |
| Assenagon Asset Management S.A. | 69,142 | $181,843 | 0.00% |
| Lindbrook Capital, LLC | 2,793 | $7,346 | 0.00% |
| Aspire Private Capital, LLC | 700 | $1,841 | 0.00% |
| Cubist Systematic Strategies, LLC | 36,917 | $97,092 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 107,738 | $283,351 | 0.00% |
| MARSHALL WACE, LLP | 214,213 | $563,380 | 0.00% |
| FEDERATED HERMES, INC. | 181,941 | $478,505 | 0.00% |
| WOLVERINE TRADING, LLC | 10,200 | $26,826 | 0.00% |
| BlackRock Inc. | 1,475,711 | $3,881,120 | 0.00% |
| Bank of New York Mellon Corp | 52,923 | $139,188 | 0.00% |
| GHP Investment Advisors, Inc. | 1,170 | $2,762 | 0.00% |
| MACQUARIE GROUP LTD | 61,255 | $161,000 | 0.00% |
| Citadel Advisors | 400 | $1,052 | 0.00% |
| Citadel Advisors | 20,100 | $52,863 | 0.00% |
| Citadel Advisors | 180,113 | $473,697 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 67,700 | $178,051 | 0.00% |
External links
This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q3 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.